Tag: the war on (some) drugs

New analysis shows ideology, not science, drove the global prohibition of psychedelics

A recent study published in Contemporary Drug Problems argues that the strict global prohibition of psychedelic drugs was driven more by political ideology and media panic than by scientific evidence of medical harm. The historical analysis reveals that the 1971 United Nations decision to heavily restrict these substances relied on cultural anxieties rather than genuine public health risks. These findings suggest that current international drug laws may need to be reevaluated to remove unnecessary barriers to modern medical research.

Psychedelics are a diverse class of substances that alter a person’s perception, mood, and cognitive processes. This category includes naturally occurring compounds found in certain plants and mushrooms, like psilocybin and mescaline, as well as synthetic drugs like lysergic acid diethylamide, commonly known as LSD. Medical professionals generally consider these substances to be physiologically safe, and they tend to have a very low risk of causing addiction.

The United Nations is an international organization founded to maintain global peace, security, and cooperation, which includes creating treaties to regulate the global trade of various drugs. In 1971, the United Nations adopted the Convention on Psychotropic Substances. This international treaty classified psychedelics under the strictest possible level of legal control, lumping them together with highly addictive substances.

A psychotropic substance is simply any chemical that alters how the brain functions, causing changes in mood or awareness. In recent years, medical interest in psychedelics has returned. Early research suggests they could help treat severe mental health conditions.

However, the strict international laws established in 1971 continue to make modern medical research very difficult. The scientists conducted this study to understand exactly how international diplomats originally decided to place psychedelics under such extreme restrictions. They wanted to uncover the historical and political forces that shaped these long-standing global drug policies.

“My legal background, an interest in history, and involvement in an organisation that promotes research into the risks and potential benefits of psychedelic compounds coalesced into my wanting to conduct this research,” explained study author Måns Bergkvist of Uppsala University.

To reconstruct the history of UN drug policy, the researchers examined primary historical documents spanning from 1963 to 1971. They gathered archival records from three specific locations: the United Nations Archives, the Swedish National Archives, and the United States National Archives. The scientists analyzed a vast collection of meeting minutes, official negotiation records, internal reports, and diplomatic resolutions.

Keep reading

Psilocybin Helps People Quit Cigarettes More Effectively Than Nicotine Patches Do, American Medical Association-Published Study Shows

Just one dose of psilocybin combined with therapy is associated with “significantly increased long-term abstinence” from cigarettes compared to nicotine patches, according to a new study published by the American Medical Association (AMA) that indicates the psychedelic “holds potential in the treatment of tobacco use disorder.”

Researchers at Johns Hopkins University School of Medicine and the University of Alabama at Birmingham conducted the study, published in JAMA Substance Use and Addiction, finding more evidence about the therapeutic potential of single-dose psilocybin in tandem with cognitive behavioral therapy (CBT).

The randomized clinical trial of cigarette smokers involved administering one high dose (30mg/70kg) of psilocybin or 8-10 weeks of Food and Drug Administration- (FDA) approved nicotine patch treatment, with both groups participating in a 13-week CBT program for smoking cessation.

“A total of 82 psychiatrically healthy adult smokers participated in the study, with 68 (82.9 percent) completing the 6-month follow-up,” the paper says. “At 6-month follow-up, 17 participants receiving psilocybin (40.5 percent) exhibited biochemically verified prolonged abstinence compared with 4 participants using the nicotine patch (10.0 percent), and 22 participants receiving psilocybin (52.4 percent) exhibited biochemically verified 7-day point prevalence abstinence compared with 10 participants using the nicotine patch (25.0 percent).”

Put another way, smokers who received psilocybin had more than six times greater odds of prolonged abstinence and more than three times greater odds of seven-day abstinence compared to the nicotine patch participants.

“In this pilot randomized clinical trial, one dose of psilocybin with manualized CBT significantly increased long-term abstinence compared with nicotine patch treatment with CBT,” the authors said. “Psilocybin abstinence rates were higher than typical treatments, suggesting promise for tobacco smoking cessation.”

Keep reading

Cannabis compounds could reverse disease affecting one-third of adults

Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.

The research, published in the British Journal of Pharmacology, found that cannabidiol (CBD) and cannabigerol (CBG) significantly reduced liver fat and improved metabolic health in experimental models.

CBD is the more widely studied non-intoxicating cannabinoid, while CBG is a less common “precursor” cannabinoid from which CBD is formed.

Unlike THC, the primary psychoactive component in cannabis, these compounds do not produce a “high,” making them viable candidates for long-term medical treatment, the study suggests.

Metabolic dysfunction-associated steatotic liver disease (MASLD) currently affects approximately one-third of the global adult population, according to health data.

The condition, which is closely linked to obesity and insulin resistance, has few approved pharmaceutical treatments, the researchers said, leaving patients to rely largely on lifestyle changes that can be difficult to maintain. 

“Our findings identify a new mechanism by which CBD and CBG enhance hepatic energy and lysosomal function,” said lead study author Joseph Tam, director of the Multidisciplinary Center for Cannabinoid Research at Hebrew University, in a press release.

The study highlights a process called “metabolic remodeling,” in which the cannabis compounds created a “backup battery” for the liver by increasing levels of phosphocreatine, a high-energy molecule stored in muscle cells.

Keep reading

GOP Congressman Running For Florida Governor Admits To Selling Marijuana Despite Opposing Legalization And Sentencing Reform

A GOP congressman running for governor in Florida who has opposed marijuana legalization in the state and sponsored federal legislation to upend a Washington, D.C. sentencing reform law has admitted for the first time that he was arrested for selling cannabis as a young adult.

Rep. Byron Donalds (R-FL), a Trump-endorsed GOP candidate vying to replace Florida Gov. Ron DeSantis (R), was pressed on the apparent disconnect during an interview with CBS Miami that aired on Saturday.

While it was previously known that Donalds faced an arrest over marijuana in 1997—only to have the charges dropped years later as part of a pre-trial diversion program—this marked the first time he’s publicly admitted to selling small amounts of cannabis and acknowledged that he benefitted from the type of criminal justice reform law he’s worked to undermine in the District of Columbia.

“Honestly, I was walking down the street, I was leaving a party, officers came up, asked me if I would empty my pockets. I said, ‘Yes, of course.’ I had a dime bag of marijuana in my pocket. That’s the story,” the congressman said. “It was bad decisions. I can’t undo that decision.”

Donalds said he sold “low-level amounts” of marijuana, reiterating that he made “terrible decisions” and that it was among the things he did in his early adulthood that he wishes he could “undo.”

“I wish I could undo [it]. I wish I could, but I can’t do that,” he said. “I would tell people, if you examine my life since 20 years old, my life has really been a story of redemption.”

But that redemption arc was made possible, in part, thanks to sentencing policy that afforded Donalds a level of relief that he’s sought to deprive D.C. residents of—a point that Rep. Jasmine Crockett (D-TX) raised during a House floor debate last year where she slammed her GOP colleague over the apparent double standard.

“Imagine standing in front of a judge with your life hanging in balance, and instead of prison you’re given a promise of mercy. Your record is wiped clean, and you’ve got a second chance at life,” Crockett said. “Imagine turning that into a promotion and you go to college and get a job and even become a member of Congress. That’s what redemption looks like.”

Keep reading

Democrats Destroy Two of Their Talking Point Lies With Their Own Votes

Sen. Katie Britt delivered a sharp rebuke on the Senate floor, accusing Democrats of attempting to defund key border security and federal law enforcement agencies while the country continues to face threats from drug trafficking, cartel violence, and national security risks tied to illegal immigration.

Britt argued that while Democrats now claim they no longer support open border policies, their current proposal would eliminate funding for Customs and Border Protection, including the Border Patrol.

According to Britt, the move would undermine agencies that have been directly responsible for reducing fentanyl-related deaths across the country.

Sen. Katie Britt delivered a sharp rebuke on the Senate floor, accusing Democrats of attempting to defund key border security and federal law enforcement agencies while the country continues to face threats from drug trafficking, cartel violence, and national security risks tied to illegal immigration.

Britt argued that while Democrats now claim they no longer support open border policies, their current proposal would eliminate funding for Customs and Border Protection, including the Border Patrol.

According to Britt, the move would undermine agencies that have been directly responsible for reducing fentanyl-related deaths across the country.

“Democrats claim they are no longer for open borders,” Britt said.

“Yet they’re now proposing to actually defund border security. Their proposal completely defunds the Customs and Border Protection, including Border Patrol.”

Britt pointed to recent data showing a decline in overdose deaths tied to fentanyl and credited CBP officers for the progress.

“Now, year over year, fentanyl deaths are down 24% when you take overdoses of drug and fentanyl deaths down 24% because of the good work of CBP, but you want to defund that. Why?”

Keep reading

When 7‑OH Fears Drive Policy by Anecdote

For generations, communities in Southeast Asia have used the leaves of Mitragyna speciosa — kratom — brewed as a drink to relieve pain and steady mood. Its principal alkaloids, mitragynine and the more potent 7‑hydroxymitragynine, act on opioid receptors and produce analgesic effects.

Kratom has since gained a significant presence in the United States, where consumers often use it as an alternative to prescription opioids or as a self-directed aid in managing withdrawal. It is sold in teas, capsules, powders, and concentrated extracts, with purified 7‑OH products increasingly appearing in vape shops, convenience stores, and online markets.

Regulators are now moving toward prohibition. Last July, Food and Drug Administration Commissioner Marty Makary and Health and Human Services Secretary Robert F. Kennedy Jr. announced plans to urge the Drug Enforcement Administration to place 7‑OH in Schedule I — the same legal category as heroin.

Supporters of these efforts argue that kratom — especially high-potency 7‑OH — could fuel the next wave of overdose deaths. But the data tell a different story.

Fatal overdoses in which 7‑OH has been implicated are exceedingly rare, and deaths linked to kratom more broadly are rarer still. In the limited cases where coroners listed kratom or 7‑OH as contributing factors, polysubstance use was the norm. Roughly two-thirds of decedents had fentanyl in their systems. About one-third had heroin present, and just under one-fifth had prescription opioids or cocaine. Around 80% had documented histories of substance misuse, and about 90% were not receiving clinical care for pain.

Each of these deaths is tragic, and any loss of life linked to psychoactive substances deserves careful scrutiny.

Keep reading

Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

The Wall Street Journal has a new teen-cannabis panic on offer: vape clouds in school bathrooms, sneaky hits during class and administrators playing cat-and-mouse with students who keep finding ways to get high. The gadgets are newer. The hardware is newer. The hiding spots may be newer, too. But the underlying behavior? Please. American teenagers did not just discover weed because a dispensary opened in town. What the Journal really found is an old adolescent ritual in updated packaging, then stretched it into a referendum on legal cannabis.

Let’s get the obvious part out of the way. Teen cannabis use is real. The risks are real. THC can be harmful to developing brains, and schools have every right to care about what students are doing on campus. But that is not the same as proving legalization created some brand-new youth cannabis crisis. That leap is where the piece gets slippery.

Because once you leave the anecdote and look at the trendline, the panic starts to wobble. The University of Michigan’s Monitoring the Future report shows past-year marijuana use among 12th graders at 26.0% in 2024, down from 35.7% in 2019. Among 8th graders, it was 7.0% in 2024, down from 11.8% in 2019. That is not an explosion. That is a decline.

Zoom out further and the same pattern holds. A 2026 Addictive Behaviors paper, “Trends in US adolescent cannabis use, 1991–2023”, found that youth cannabis use rose through the 1990s, peaked in 1999 and then broadly declined. Lifetime use fell from 47.3% in 1999 to 30.1% in 2023. Recent use dropped from 27.1% to 17.8%. Early initiation fell too. In other words, if you want to tell a dramatic story about teen cannabis, the most inconvenient fact is that the peak is a quarter-century behind us.

And if the argument is specifically that legalization caused kids to start using more, the best recent policy literature does not back that up either. A 2024 JAMA Psychiatry study, “Recreational Marijuana Laws and Teen Marijuana Use, 1993-2021”, found no evidence that recreational marijuana laws were associated with current or frequent teen use. A separate 2024 JAMA Pediatrics study, “Recreational Cannabis Legalization, Retail Sales, and Adolescent Substance Use Through 2021”, found no net increases in adolescent cannabis, alcohol, cigarette or e-cigarette use tied to recreational legalization or retail sales. That does not mean every concern is fake. It means the Journal is hinting at a causal story the evidence does not support.

That is the framing trick. The article keeps pointing to real things, then attaching them to the wrong villain. Teens getting THC vapes from older friends? Real. Peer-to-peer sales through Snapchat? Real. Bad packaging that looks too much like candy? Also real. But none of that means adult legality itself is the root problem. If a kid gets cannabis from an older sibling, a sloppy adult or some classmate running a side hustle through social media, that is a diversion problem. A safeguards problem. An adults-failing-kids problem. It is not proof that legal access for adults was the mistake. If an eighth grader grabs a parent’s car keys and takes off, the problem is not that cars are legal for adults. The problem is access, supervision and adults failing to secure something meant for grown people.

Keep reading

Surreal NCAA Scandal: California Basketball Coach Was Moonlighting in Multiple States as a Pimp

Even in the large, expansive, and sordid history of college sports scandals, this one might be one of the strangest.

According to ESPN, California State University, Bakersfield, has been rocked by a surreal scandal that has overshadowed the fact that the team is dead last in the Big West Conference.

(Which is probably for the best for the Roadrunners, given that they’re 8-22.)

But it doesn’t appear that Cal State Bakersfield’s athletic department will be answering any questions about that putrid record any time soon.

Instead, the department will undoubtedly be peppered with questions about “temporary assistant coach” Kevin Mays.

In August, then-Cal State Bakersfield basketball head coach Rod Barnes received an anonymous email alleging that Mays had been operating as a pimp across four different states.

“FIX IT OR THE WHOLE STAFF WILL FALL,” the tipster, who had identified a woman allegedly being trafficked by Mays, said in the email.

The tipster added that it was a “first warning and a final warning.”

Barnes would forward that email to school officials, which prompted an investigation that would eventually lead to criminal charges being pressed against Mays.

Mays is currently being held without bail as he faces an extensive list of charges — 11 in total — spanning both felonies and misdemeanors.

Among the most serious allegations are felony counts of pimping, along with charges tied to illegal weapons and drug trafficking.

Prosecutors accused him of possessing automatic firearms and high-capacity magazines, as well as methamphetamine and marijuana that authorities say were intended for distribution. Those allegations alone carry significant penalties if proven in court.

In addition, investigators claimed Mays had more than 600 images of child sexual abuse material and distributed obscene content involving a minor.

Despite the damning list of accusations, Mays has entered a plea of not guilty to every charge.

The bizarre scandal unsurprisingly took the sports world by storm.

Keep reading

US Military Conducts Strike on Narco-Terrorist Cell in Ecuador (UNCLASSIFED VIDEO)

US Southern Command on Friday announced the US conducted a military strike on a narco-terrorist network in Ecuador.

“At the order of Secretary of War Hegseth, SOUTHCOM Commander Gen. Francis L. Donovan directed the joint force to support Ecuadorian forces conducing lethal kinetic operations against Designated Terrorist Organizations within Ecuador March 6,” US Southern Command said.

“We are advancing alongside our partners in the fight against narcoterrorism,” General Donovan said.

“I congratulate our joint forces and the Ecuadorian armed forces for the successful operation against narcoterrorists in Ecuador. This collaborative and decisive action is a strategic success for all nations in the Western Hemisphere committed to disrupting and defeating narcoterrorism.” General Donovan said.

The Pentagon released a statement on the joint strike:

Under the leadership of President Trump and Secretary Hegseth, the Department is uniting partners across the Western Hemisphere to detect, disrupt, and destroy designated terrorist organizations that fuel violence and corruption.

We commend President Noboa, the Government of Ecuador, and the brave troops of Ecuador’s defense and security forces for their partnership in the successful operation against a narco-terrorist supply complex today, disrupting their operations and logistics.

At the request of Ecuador, the Department of War executed targeted action to advance our shared objective of dismantling narco-terrorist networks.

This operation demonstrates the power of coordinated action and sends a clear message: narco-terrorist networks will not find refuge in our hemisphere.

The United States remains steadfast in supporting nations that stand against narcoterrorism. Together, we will dismantle trafficking and corruption networks, hold these organizations accountable, and restore peace through strength.

US Southern Command released unclassified video of the strike.

Keep reading

Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To Mitigate Suicide Crisis

Multiple veterans groups advised congressional lawmakers about the need to continue exploring psychedelics and marijuana as alternative treatment options for the military veteran population at recent hearings on Capitol Hill. And one veterans advocate cited his experience attending President Donald Trump’s Oval Office signing event for a cannabis rescheduling order as an example of progress in the fight for such alternatives.

At a series of joint hearings before the House and Senate Veterans’ Affairs Committees last month and this week, representatives of veterans service organizations (VSOs) testified about the need to promote innovative approaches in mental health treatment, in part to help mitigate the suicide crisis that’s disproportionately impacted those who’ve served.

Dan Wiley, national commander of the American Legion, said on Wednesday that the organization’s “number one priority” is “ending veteran suicide,” which involves finding alternatives to conventional therapies because “pills and therapy have objectively not worked.”

“We need stronger transition programs, innovative therapies and improved safeguards to medication management,” he said, while going out of his way to add that, after a decade with the American Legion, “I was proud to be in the Oval Office as the president signed an executive order that reclassified cannabis as a Schedule III drug.”

“This allows for federal research on how it can reduce drivers of suicide,” he said. “Now the American Legion does not support use of illegal drugs, but we strongly support research that could result in new, effective treatments.”

Keep reading